Australia and New Zealand Ultrasound Devices Market Report and Forecast 2024-2032

Australia and New Zealand Ultrasound Devices Market Outlook

The Australia and New Zealand ultrasound devices market size is anticipated to grow at a CAGR of 6.07% during the forecast period of 2024-2032, driven by the increasing prevalence of cardiovascular diseases across the globe.

Australia and New Zealand Ultrasound Devices Market Overview

The growth of the market  is being driven by the advancements in medical technology and increasing healthcare awareness. This dynamic market is witnessing a rising demand for cutting-edge ultrasound devices, including portable and 3D/4D imaging systems. The regions’ healthcare infrastructure development, coupled with a growing elderly population, contributes to the expanding market. Additionally, the emphasis on early disease detection and prenatal care fuels the adoption of ultrasound technology. The Australia and New Zealand ultrasound devices market growth is also driven by the growing burden of chronic diseases, like cardiovascular diseases and cancer, along with increased healthcare investments and technological advancements.

According to According to the cancer data in Australia, there were approximately 3,830 new cases of thyroid cancer diagnosed in Australia, with 1,070 cases in males and 2,760 in females. The report also indicates that the likelihood of being diagnosed with thyroid cancer by the age of 85 is projected to be 1 in 83 (1.2%), with specific probabilities for males (1 in 145 or 0.69%) and females (1 in 58 or 1.7%). Ultrasound, being a convenient and widely available imaging modality that does not involve ionizing radiation, is considered ideal for detecting and evaluating thyroid nodules. Consequently, the increasing incidence of thyroid cancer in the country is expected to drive the Australia and New Zealand ultrasound devices market demand.

Increasing Funding by the Government Strengthens Imaging Services

The Australian Government's augmented financial support for enhancing imaging services is anticipated to fuel the market expansion. The government  allocated additional funds for the expansion of the Heart of Australia Program in April 2022, amounting to approximately USD 12.0 million. This program extends mobile medical clinic services throughout northern Queensland, offering heart monitoring and various healthcare services. The government's commitment to cardiovascular care delivery is expected to boost the demand for ultrasound equipment, contributing to the Australia and New Zealand ultrasound devices market share.

Increasing Usage of High-intensity Focused Ultrasound Source

High-intensity focused ultrasound is increasingly employed in the treatment of both primary and metastatic tumors due to its precise tumor identification capabilities during ablation. In cases where patients exhibit substantial medical co-morbidities, rendering them high-risk candidates for surgery, or possess lower liver function restricting hepatectomy, high-intensity focused ultrasound emerges as a viable therapeutic option for addressing liver tumors. High-intensity focused ultrasound emerges as a promising and safe alternative for the minimally invasive treatment of localized prostate cancer.

Notably, recent research published by the Mayo  Foundation in August underscores the growing interest in mitigating treatment-related side effects associated with prostate cancer by targeting a specific portion of the affected prostate. Focal therapy, utilizing high-intensity focused ultrasound (HIFU), proves effective in addressing this concern. HIFU precisely targets the most aggressive tumor, sparing the surrounding prostate structures. This approach is widely accepted in treating various cancers, including kidney cancers, where only the tumor is removed or ablated, leaving the rest of the organ intact. Consequently, the increased demand for HIFU systems may drive their adoption in Australian healthcare for minimally invasive prostate cancer treatment.

Australia and New Zealand Ultrasound Devices Market Segmentations

Market Breakup by Type

• Stationary Ultrasound

• Portable Ultrasound

Market Breakup by Technology

• Advanced2D Ultrasound Imaging

• 3D and 4D Ultrasound Imaging

• Doppler Imaging

• High-intensity Focused Ultrasound

Market Breakup by Applications

• Anesthesiology

• Cardiology

• Gynecology/Obstetrics

• Musculoskeletal

• Radiology

• Primary Care

• Critical Care

• Emergency Medicine

Market Breakup by Portability

• Handheld

• Compact

• Cart/Trolley
  • Point-of-Care Cart/Trolley Based Ultrasound
  • Higher-end Cart/Trolley Based Ultrasound

Market Breakup by End User

• Hospitals

• Imaging Centres

• Research Centres

Market Breakup by Country

• Australia

• New Zealand

Australia and New Zealand Ultrasound Devices Market: Competitor Landscape

The ultrasound devices market in Australia and New Zealand exhibits a moderate level of competitiveness, with prominent players. Key market leaders include Mindray Medical International Limited, Siemens Healthineers AG, GE Healthcare, Fujifilm Holdings Corporation, and Koninklijke Philips NV, among others.

In November 2022, Caption  Health disclosed the receipt of regulatory approvals from Health Canada's Medical Devices Directorate and Australia's Therapeutic Goods Administration to market its Caption AI technology platform. This innovative platform enables healthcare professionals in Australia and Canada, regardless of prior sonography experience, to conduct cardiac ultrasounds.

The key features of the Australia and New Zealand ultrasound devices market report includes patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

The major companies in the market are as follows:

• Canon Medical Systems Corporation

• SonoScape Medical Corp

• Fujifilm Holdings Corporation

• GE Healthcare

• Hologic Inc.

• Koninklijke Philips NV

• Mindray Medical International Limited

• Samsung Electronics Co. Ltd.

• Esaote SPA

• Siemens Healthineers AG

• ALPINION MEDICAL SYSTEMS Co., Ltd.

• CHISON Medical Technologies Co., Ltd.

• SAMSUNG HEALTHCARE

• Analogic Corporation

• General Electric

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

Australia and New Zealand Ultrasound Devices Market Report Snapshots

Australia and New Zealand Ultrasound Devices Market Size

Australia and New Zealand Ultrasound Devices Companies